-+ 0.00%
-+ 0.00%
-+ 0.00%

EMA'S CHMP: RECOMMENDED EXTENSIONS OF INDICATION FOR AREXVY, ASPAVELI, DOVPRELA, ELUCIREM, EYLEA, NUCALA, RECARBRIO, SIMPONI, UPLIZNA, VUEWAY

Reuters·12/12/2025 13:35:50

Please log in to view news